Access to anti-retroviral drugs, female in Kenya
Kenya: Access to anti-retroviral drugs, female was 90.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Kenya, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Kenya recorded 90.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.1% on the previous year and up 50.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Kenya peaked at 90.0% in 2024 and was at its lowest, 0.0%, in 2000.
Kenya ranks 27th of 141 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Kenya, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 2.0% | — |
| 2005 | 4.0% | +100.0% |
| 2006 | 9.0% | +125.0% |
| 2007 | 12.0% | +33.3% |
| 2008 | 17.0% | +41.7% |
| 2009 | 23.0% | +35.3% |
| 2010 | 30.0% | +30.4% |
| 2011 | 42.0% | +40.0% |
| 2012 | 47.0% | +11.9% |
| 2013 | 51.0% | +8.5% |
| 2014 | 60.0% | +17.6% |
| 2015 | 71.0% | +18.3% |
| 2016 | 81.0% | +14.1% |
| 2017 | 87.0% | +7.4% |
| 2018 | 85.0% | -2.3% |
| 2019 | 82.0% | -3.5% |
| 2020 | 82.0% | +0.0% |
| 2021 | 87.0% | +6.1% |
| 2022 | 88.0% | +1.1% |
| 2023 | 89.0% | +1.1% |
| 2024 | 90.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.7% | 0.0% | 23.0% | 10 |
| 2010s | 63.6% | 30.0% | 87.0% | 10 |
| 2020s | 87.2% | 82.0% | 90.0% | 5 |
Countries ranked near Kenya
More gender data for Kenya
- Child population (UN estimates and projections) 21,579 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.8794 % change on previous year (2030)
- Population 41,524 (2030)
- Working-age population (UN estimates and projections) 41,524 (2030)
- Population (UN estimates and projections), annual growth rate 2.3 % change on previous year (2030)
- Age population, age 00, female, interpolated 740,912 (2025)
- Age population, age 00, male, interpolated 751,960 (2025)
- Age population, age 01, female, interpolated 725,839 (2025)
- Age population, age 01, male, interpolated 736,424 (2025)
- Age population, age 02, female, interpolated 712,907 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Kenya?
- Access to anti-retroviral drugs, female in Kenya was 90.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Kenya?
- The highest recorded value was 90.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Kenya?
- The lowest recorded value was 0.0% in 2000.
- How does Kenya rank for access to anti-retroviral drugs, female?
- Kenya ranks 27th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Kenya?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is volatile.
- Where does this Kenya data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.